Tech Company Financing Transactions

GreenLight Biosciences Funding Round

GreenLight Biosciences secured a $102 million Series D funding round on 6/18/2020. Investors included Morningside Group, Baird Capital and Continental Grain Company.

Transaction Overview

Company Name
GreenLight Biosciences
Announced On
6/18/2020
Transaction Type
Venture Equity
Amount
$102,000,000
Round
Series D
Investors

Morningside Group (Lead Investor) (Jason Dinges)

Baird Capital (Michael Liang)

Continental Grain Company

Cormorant Asset Management

Fall Line Capital (Eric O'Brien)

Lewis & Clark Ventures

Lupa Systems

MLS Capital Fund II (Ganesh Kishore)

S2G Ventures (Matthew Walker)

Tao Capital Partners

Proceeds Purpose
The new funding will drive the expansion of GreenLight's human health efforts into new platforms like RNA-based therapeutics.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Boston Ave. 1000
Medford, MA 02155
USA
Phone
(888) 262-0893
Website
www.greenlightbiosciences.com
Email Address
[email protected]
Overview
At GreenLight we develop clean biochemical processes through our proprietary Cell Free BioProcess technology.
Profile
GreenLight Biosciences LinkedIn Company Profile
Social Media
GreenLight Biosciences Company Twitter Account
Company News
GreenLight Biosciences News
Facebook
GreenLight Biosciences on Facebook
YouTube
GreenLight Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrey Zarur
  Andrey Zarur LinkedIn Profile  Andrey Zarur Twitter Account  Andrey Zarur News  Andrey Zarur on Facebook
Chief Financial Officer
Susan Keefe
  Susan Keefe LinkedIn Profile  Susan Keefe Twitter Account  Susan Keefe News  Susan Keefe on Facebook
Chief Operating Officer
Carole Cobb
  Carole Cobb LinkedIn Profile  Carole Cobb Twitter Account  Carole Cobb News  Carole Cobb on Facebook
VP - Bus. Development
Mick Messman
  Mick Messman LinkedIn Profile  Mick Messman Twitter Account  Mick Messman News  Mick Messman on Facebook
VP - Bus. Development
Marta Ortega-Valle
  Marta Ortega-Valle LinkedIn Profile  Marta Ortega-Valle Twitter Account  Marta Ortega-Valle News  Marta Ortega-Valle on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/18/2020: Dumpling venture capital transaction
Next: 6/18/2020: CounterCraft venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.